share_log

Insider Spends HK$478k Buying More Shares In EuroEyes International Eye Clinic

Insider Spends HK$478k Buying More Shares In EuroEyes International Eye Clinic

内幕人士花费47.8万港元购买更多EuroEyes国际眼科诊所股份
Simply Wall St ·  02/02 17:06

Whilst it may not be a huge deal, we thought it was good to see that the EuroEyes International Eye Clinic Limited (HKG:1846) VP of Denmark & Executive Director, Jannik Jørgensen, recently bought HK$478k worth of stock, for HK$4.90 per share. However, it only increased their shares held by 1.6%, and it wasn't a huge purchase by absolute value, either.

尽管这可能不是什么大问题,但我们认为很高兴看到丹麦欧眼国际眼科诊所有限公司(HKG: 1846)副总裁兼执行董事詹尼克·约根森最近以每股4.90港元的价格购买了价值47.8万港元的股票。但是,它仅增加了1.6%的股份,按绝对价值计算,这也不是一次巨额收购。

EuroEyes International Eye Clinic Insider Transactions Over The Last Year

EuroEyes国际眼科诊所去年的内幕交易

The Founder Jörn Jörgensen made the biggest insider purchase in the last 12 months. That single transaction was for HK$7.8m worth of shares at a price of HK$5.19 each. That means that even when the share price was higher than HK$4.95 (the recent price), an insider wanted to purchase shares. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

创始人约恩·约尔根森进行了过去12个月中最大规模的内幕收购。这笔单笔交易是价值780万港元的股票,每股价格为5.19港元。这意味着,即使股价高于4.95港元(最近的价格),内部人士也想购买股票。从那以后,他们的观点可能发生了变化,但至少这表明他们当时感到乐观。对我们来说,考虑内部人士为股票支付的价格非常重要。如果他们支付的费用高于当前价格,通常会更令人鼓舞,因为这表明即使在更高的水平上,他们也看到了价值。

In the last twelve months insiders purchased 1.78m shares for HK$9.1m. On the other hand they divested 5.00k shares, for HK$29k. In total, EuroEyes International Eye Clinic insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

在过去的十二个月中,内部人士以910万港元购买了178万股股票。另一方面,他们以2.9万港元的价格剥离了5.00万股股票。总体而言,EuroEyes国际眼科诊所内部人士的购买量超过了去年的卖出量。您可以看到下图所示的去年的内幕交易(公司和个人)。如果你想确切地知道谁卖了、卖了多少以及何时出售,只需点击下图!

insider-trading-volume
SEHK:1846 Insider Trading Volume February 2nd 2024
SEHK: 1846 内幕交易量 2024 年 2 月 2 日

EuroEyes International Eye Clinic is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

EuroEyes国际眼科诊所并不是业内人士唯一买入的股票。因此,来看看这份包含内幕买入的成长型公司的免费名单吧。

Insider Ownership Of EuroEyes International Eye Clinic

EuroEyes 国际眼科诊所的内部所有权

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own 58% of the company, currently worth about HK$949m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

许多投资者喜欢查看公司内部人士拥有多少股份。通常,内部人士的所有权越高,内部人士长期建立公司的可能性就越大。EuroEyes国际眼科诊所内部人士拥有该公司58%的股份,根据最近的股价,目前价值约9.49亿港元。内部人士的这种重要所有权通常会增加公司为所有股东的利益而经营的机会。

What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?

EuroEyes 国际眼科诊所的内幕交易会告诉我们什么?

The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. That's what I like to see! Of course, the future is what matters most. So if you are interested in EuroEyes International Eye Clinic, you should check out this free report on analyst forecasts for the company.

最近的内幕收购令人振奋。对去年交易的分析也使我们充满信心。除了较高的内部所有权外,该分析还表明,内部人士对EuroEyes国际眼科诊所相当看好。这就是我喜欢看到的!当然,未来才是最重要的。因此,如果你对EuroEyes国际眼科诊所感兴趣,你应该查看这份关于该公司分析师预测的免费报告。

But note: EuroEyes International Eye Clinic may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:EuroEyes国际眼科诊所可能不是最好的买入股票。因此,来看看这份投资回报率高、债务低的有趣公司的免费清单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发